The 2018 ACC/AHA Lipid Guidelines: A Little More or Less Canadian?doi:10.1016/j.cjca.2019.03.003George Thanassoulis MDJean Gregoire MDGlen J. Pearson BScPhm, PharmDCanadian Journal of Cardiology
基于2013年以后的临床研究证据,2018 AHA/ACC血胆固醇管理指南[1]做出了对于联合降脂治疗的推荐:对于临床ASCVD患者,最大耐受剂量他汀治疗后,风险评估为极高危,若LDL-C≥70mg/dL (1.8mmol/L),加用依折麦布是合理的(IIa类推荐,B级证据);对于风险评估为极高危的临床ASC...
Therefore, in the AHA/ACC guideline, the treatment of primary prevention patients is limited to statin therapy, with no consideration of an LDL-C goal; furthermore, there is no specific recommendation for the addition of a nonstatin lipid-lowering therapy except for patients with heterozygous fam...
[4] Rao S V, O'Donoghue M L, Ruel M, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Asso...
Impact of new lipid management guidelines on the treatment of extreme and very high‐risk patients: AACE/ACE and AHA/ACC guidelinesTRANSIENT ischemic attackANKLE brachial indexLIPIDSCORONARY artery bypassANGINA pectorisPERIPHERAL vascular diseasesdoi:10.1111/1753-0407.12998Paul S. Jellinger...
Fig. 1. Estimated number and percentage of US adults with ASCVD recommended for and taking add-on lipid-lowering therapy according to the 2018 AHA/ACC multi-society cholesterol guideline Abbreviations: AHA/ACC - American Heart Association/American College of Cardiology, ASCVD - atherosclerotic cardiov...
LipidAssociation,NLA)以及美国心血管预防护理学会反映了冠状动脉疾病患者从急性到慢性的连续过程,适 (PreventiveCardiovascularNursesAssociation,PCNA)用于门诊环境中。同时有益于指导我国基层医疗卫生机 联合发布了《2023AHA/ACC/ACCP/ASPC/NLA/PCNA慢构全科医生对冠状动脉疾病的整体性认知,以及制订综 性冠状动脉疾病患者管...
Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study. BMJ. 2018;362:k2357. https://doi.org/10.1136/bmj.k2357. Article PubMed PubMed Central Google Scholar Abariga ...
Data of participants aged ≥20 years from the fifth phase (2012–2015) of the Tehran lipid and glucose study (N = 10,576) were analyzed, using survey analysis. The weighted prevalence of hypertension among those not on anti-hypertensive medications was 42.7 and 12.6%, applying the ACC/AHA ...
1 The impact of 2017ACC/AHA and JNC8 guidelines on the prevalence, awareness (a), treatment, and control (b) of hypertension in different age groups in Khuzestan province, comparing to the national average rates of prevalence, awareness, treatment, and control of hypertension Sadeghi et al. ...